Publications by authors named "Warner Huh"

Article Synopsis
  • The study aims to evaluate how the growth of gynecologic oncology fellowships in the U.S. will impact surgical volume for both trainees and practicing oncologists over the next two decades.
  • It projects a 14% increase in cancer cases, mainly endometrial cancer, while the number of new surgical patients per oncologist will decline significantly due to current trainee numbers.
  • The findings suggest that if fellowships do not expand, practicing oncologists will face a nearly 41% decrease in their caseload, highlighting the need for careful planning in training programs.
View Article and Find Full Text PDF

Introduction: The objective of this study was to determine the trends in benign surgery in GO practice across the United States.

Methods: This was a retrospective cohort analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database from 2015 to 2021. Subjects were selected by filtering for cases of hysterectomy using current procedural terminology (CPT codes).

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the effectiveness of distress screening methods in identifying financial hardship (FH) among gynecologic cancer patients compared to a dedicated FH screening approach.
  • The research involved screening 364 patients using both distress measures and specialized financial assessments, revealing that the distress screening had moderate sensitivity (57%) but high specificity (77%) for detecting FH.
  • Results indicated that 24% of patients screened positive for FH, emphasizing the need for dedicated screening since many affected individuals might not be identified through distress screening alone.
View Article and Find Full Text PDF

Objectives: The Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee developed recommendations for dual stain (DS) testing with CINtec PLUS Cytology for use of DS to triage high-risk human papillomavirus (HPV)-positive results.

Methods: Risks of cervical intraepithelial neoplasia grade 3 or worse were calculated according to DS results among individuals testing HPV-positive using data from the Kaiser Permanente Northern California cohort and the STudying Risk to Improve DisparitiES study in Mississippi. Management recommendations were based on clinical action thresholds developed for the 2019 American Society for Colposcopy and Cervical Pathology Risk-Based Management Consensus Guidelines.

View Article and Find Full Text PDF

Objectives: The Enduring Consensus Cervical Cancer Screening and Management Guidelines (Enduring Guidelines) effort is a standing committee to continuously evaluate new technologies and approaches to cervical cancer screening, management, and surveillance.

Methods And Results: The Enduring Guidelines process will selectively incorporate new technologies and approaches with adequate supportive data to more effectively improve cancer prevention for high-risk individuals and decrease unnecessary procedures in low-risk individuals. This manuscript describes the structure, process, and methods of the Enduring Guidelines effort.

View Article and Find Full Text PDF

Objective: To assess trends and differences in patient characteristics, complications, and distributions of hysterectomy for benign indications by benign gynecologists (BG) and gynecologic oncologists (GO).

Methods: This retrospective cohort study identified patients undergoing hysterectomy for benign indications using the National Surgical Quality Improvement Program data from 2014 to 2021. Exclusions were made for gynecologic or disseminated cancers, ascites, non-gynecologic surgeons, and cesarean hysterectomies.

View Article and Find Full Text PDF

This Research Letter summarizes all updates to the 2019 Guidelines through September 2023, including: endorsement of the 2021 Opportunistic Infections guidelines for HIV+ or immunosuppressed patients; clarification of use of human papillomavirus testing alone for patients undergoing observation for cervical intraepithelial neoplasia 2; revision of unsatisfactory cytology management; clarification that 2012 guidelines should be followed for patients aged 25 years and older screened with cytology only; management of patients for whom colposcopy was recommended but not completed; clarification that after treatment for cervical intraepithelial neoplasia 2+, 3 negative human papillomavirus tests or cotests at 6, 18, and 30 months are recommended before the patient can return to a 3-year testing interval; and clarification of postcolposcopy management of minimally abnormal results.

View Article and Find Full Text PDF

Background: Standard treatment for locally advanced cervical cancer is chemoradiotherapy, but many patients relapse and die of metastatic disease. We aimed to determine the effects on survival of adjuvant chemotherapy after chemoradiotherapy.

Methods: The OUTBACK trial was a multicentre, open-label, randomised, phase 3 trial done in 157 hospitals in Australia, China, Canada, New Zealand, Saudi Arabia, Singapore, and the USA.

View Article and Find Full Text PDF

The original vision of the field of gynecologic oncology was to establish a multidisciplinary approach to the management of patients with gynecologic cancers. Fifty years later, scientific advances have markedly changed the overall practice of gynecologic oncology, but the profession continues to struggle to define its value-financial and otherwise. These issues were examined in full at the Society of Gynecologic Oncology (SGO) Future of the Profession Summit and the purpose of this document is to summarize the discussion, share the group's perceived strengths, weaknesses, opportunities, and threats (SWOT) for gynecologic oncologists, further educate members and others within the patient care team about the unique role of gynecologic oncologists, and plan future steps in the short- and long- term to preserve the subspecialty's critical mission of providing comprehensive, longitudinal care for people with gynecologic cancers.

View Article and Find Full Text PDF

Cervical cancer remains a significant disease in the United States. Although the human papillomavirus (HPV) vaccine has been approved for those aged 9-26 years and for some individuals up to age 45 years, there are many circumstances in which health care professionals may not know whether the vaccine should be recommended, such as for patients with previous infection, health care workers, and those older than age 26 years. This article highlights the evidence that the HPV vaccine is a safe and highly effective way to prevent cervical cancer, with the strongest predictor of vaccine uptake being practitioner recommendation.

View Article and Find Full Text PDF

Objective: The Lifestyle Intervention for oVarian cancer Enhanced Survival (LIVES) is a national study of a combined diet and physical activity intervention for stage II-IV ovarian cancer survival, an under-represented cancer in lifestyle behavioral intervention research. Here, we present the data on recruitment, retention, and baseline demographic, clinical and lifestyle behavior characteristics of the LIVES study participants.

Methods: The LIVES study (NRG Oncology/GOG 0225) is a Phase III diet plus physical activity intervention trial testing the hypothesis that ovarian cancer survivors in the lifestyle intervention will demonstrate better progression-free survival than those in the control condition.

View Article and Find Full Text PDF

Background: Anti-Asian violence increased during the COVID-19 pandemic. Asian American/Pacific Islanders (AAPI) represent a diverse population experiencing a long history of stereotyping and exclusionism; however, this group is often left out of diversity/inclusion conversations. In academic medicine, AAPI are under-represented in leadership.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated how COVID-19 affects patients with gynecologic cancers, looking at aspects like their treatment changes and clinical outcomes in the U.S.
  • A registry captured data from 348 patients, finding that 36% had active cancer at the time of their COVID-19 diagnosis, with 28% experiencing delays or changes in treatment due to the infection.
  • Key findings included an increased risk of hospitalization and death associated with factors like active malignancy and non-White race, with 5% of the total patient cohort dying within 30 days after diagnosis.
View Article and Find Full Text PDF
Article Synopsis
  • - The aim of the study was to gather insights from ovarian cancer patients about their job-related challenges and the resources they use or need to manage the impact of cancer on their work life.
  • - Twenty-two ovarian cancer patients were interviewed, revealing issues like reduced productivity, fears of job loss, and the need for caregiver support due to treatment side effects, as well as the importance of a supportive work environment.
  • - The study suggests that cancer care teams should actively address patients' employment concerns, improve treatment logistics, enhance resource availability, and facilitate communication between patients and their employers.
View Article and Find Full Text PDF

Background: To determine whether race and ethnicity impacts patient adherence to follow-up for colposcopy after abnormal cervical cancer screening.

Methods: This retrospective chart review included women that were randomly selected from patients presenting to our colposcopy clinic from 1/2019 to 12/2019. Inclusion criteria were females age ≥21 years-old and appropriate referral for colposcopy.

View Article and Find Full Text PDF

Objective: Distress screening and management is a recommended component of oncology care. Our objective was to evaluate distress rate, sources, and compliance with psychosocial follow-up among ovarian cancer patients receiving chemotherapy.

Methods: We reviewed patient distress surveys completed by ovarian cancer patients receiving chemotherapy from 10/2017-6/2019.

View Article and Find Full Text PDF

Objectives: In the 2019 ASCCP Risk-Based Management Consensus Guidelines, clinical management decisions are based on immediate and 5-year cervical intraepithelial neoplasia (CIN) 3+ risk estimates. However, data for technologies other than human papillomavirus testing and cytology may be limited to clinical trials and observational studies of shorter duration than 5 years. To enable decisions about 1- or 3-year intervals, 3-year CIN 3+ risk equivalents to 5-year CIN 3+ risk thresholds were generated.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluates the effectiveness of a bipolar electrocautery device for complete salpingectomy during cesarean sections, aiming to improve completion rates, reduce operative time, and increase surgeon satisfaction compared to standard techniques.
  • A total of 39 women were included in the study using the bipolar device, showing a 100% success rate, while previous methods had lower success rates (95% for BTL and 67.5% for the suture-cut-tie method).
  • Results indicated that the device significantly shortened the operative time and improved overall performance of the salpingectomy procedure, with surgeons reporting better satisfaction when using the device compared to traditional techniques.
View Article and Find Full Text PDF

Objective: Our objective was to evaluate uptake and satisfaction with an out-of-pocket (OOP) cost tracker as a means for cancer patients to manage their personalized costs of care and to identify characteristics associated with usage.

Methods: Within a longitudinal survey evaluating financial toxicity among gynecologic cancer patients on active systemic therapy over a 6-month period, we provided paper worksheets for participants to voluntarily track expenses. We assessed usage and satisfaction at 3 and 6 months using frequency and percentage.

View Article and Find Full Text PDF

Background: Estimates of the humoral immune response to incident human papillomavirus (HPV) infections are limited.

Methods: In this post hoc analysis of 3875 women aged 16-23 years from a 4-valent HPV vaccine trial (NCT00092482), HPV seroprevalence on day 1 was measured with a 9-valent HPV (HPV 6/11/16/18/31/33/45/52/58) competitive Luminex immunoassay and compared with cervical/external genital HPV detection by polymerase chain reaction. In the control group, among women who were HPV DNA‒negative on day 1, seroconversion following initial HPV detection was estimated using Kaplan-Meier methods.

View Article and Find Full Text PDF
Article Synopsis
  • * A retrospective study analyzed data from 2001 to 2018 to assess the relationship between HPV vaccination, screening, and the occurrence of HPV-related cancers, focusing on various demographics.
  • * Results indicated that out of over 657,000 HPV-associated cancer cases, the majority affected women (59.8%), particularly cervical cancer, while data revealed significant variations in cancer incidence based on race and vaccination status.
View Article and Find Full Text PDF

Background: Type 3 transformation zone (TZ) of the cervix has been shown to be associated with a four to five-fold increased risk of missed precancerous/cancerous lesions. The aim of this study was to evaluate the effect of intravaginal misoprostol on the TZ among women with Type 3 TZ in Cameroon.

Materials And Methods: A single dose of vaginal misoprostol (400 mcg or 600 mcg) was administered as part of the plan of care for women with Type 3 TZ during cervical cancer screening.

View Article and Find Full Text PDF